Sort   by:  
 Page size 
UnknownEmpagliflozin reduces Ca/calmodulin-dependent kinase II activity in isolated ventricular cardiomyocytes.
Not available
S-EPMC6073019 | biostudies-literature
UnknownReporting of Safety Events during Anti-VEGF Treatment: Pharmacovigilance in a Noninterventional Trial.
Not available
S-EPMC7558801 | biostudies-literature
UnknownLong-term effects of empagliflozin on excitation-contraction-coupling in human induced pluripotent stem cell cardiomyocytes.
Not available
S-EPMC7679329 | biostudies-literature
UnknownClinical Effectiveness of Newborn Screening for Spinal Muscular Atrophy: A Nonrandomized Controlled Trial.
Not available
S-EPMC11002769 | biostudies-literature
Sort   by:  
 Page size